K Jane Grande-Allen

Author PubWeight™ 47.01‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Calcific aortic valve disease: not simply a degenerative process: A review and agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Executive summary: Calcific aortic valve disease-2011 update. Circulation 2011 2.73
2 Matrix development in self-assembly of articular cartilage. PLoS One 2008 1.67
3 Review. Hyaluronan: a powerful tissue engineering tool. Tissue Eng 2006 1.54
4 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro. Mol Pharmacol 2003 1.47
5 Effects of static and cyclic loading in regulating extracellular matrix synthesis by cardiovascular cells. Cardiovasc Res 2006 1.36
6 Age-related changes in collagen synthesis and turnover in porcine heart valves. J Heart Valve Dis 2007 1.19
7 Bioactive polymer/extracellular matrix scaffolds fabricated with a flow perfusion bioreactor for cartilage tissue engineering. Biomaterials 2010 1.16
8 The effects of mitral regurgitation alone are sufficient for leaflet remodeling. Circulation 2008 1.15
9 Flexural characterization of cell encapsulated PEGDA hydrogels with applications for tissue engineered heart valves. Acta Biomater 2011 1.14
10 Valve proteoglycan content and glycosaminoglycan fine structure are unique to microstructure, mechanical load and age: Relevance to an age-specific tissue-engineered heart valve. Acta Biomater 2008 1.08
11 The use of collagenase III for the isolation of porcine aortic valvular interstitial cells: rationale and optimization. J Heart Valve Dis 2007 1.04
12 Age-related changes in material behavior of porcine mitral and aortic valves and correlation to matrix composition. Tissue Eng Part A 2010 1.04
13 Synthesis of glycosaminoglycans in differently loaded regions of collagen gels seeded with valvular interstitial cells. Tissue Eng 2007 0.99
14 Utility and control of proteoglycans in tissue engineering. Tissue Eng 2007 0.95
15 Age-related changes in aortic valve hemostatic protein regulation. Arterioscler Thromb Vasc Biol 2013 0.95
16 Significant changes in mitral valve leaflet matrix composition and turnover with tachycardia-induced cardiomyopathy. Circulation 2009 0.93
17 Synthesis and conformational evaluation of a novel gene delivery vector for human mesenchymal stem cells. Biomacromolecules 2008 0.92
18 Phenotypic characterization of isolated valvular interstitial cell subpopulations. J Heart Valve Dis 2006 0.91
19 A three-dimensional co-culture model of the aortic valve using magnetic levitation. Acta Biomater 2013 0.90
20 Fabrication and mechanical evaluation of anatomically-inspired quasilaminate hydrogel structures with layer-specific formulations. Ann Biomed Eng 2012 0.90
21 Core protein dependence of epimerization of glucuronosyl residues in galactosaminoglycans. J Biol Chem 2002 0.89
22 Assembly of a three-dimensional multitype bronchiole coculture model using magnetic levitation. Tissue Eng Part C Methods 2013 0.89
23 Cell viability mapping within long-term heart valve organ cultures. J Heart Valve Dis 2004 0.88
24 Reversible secretion of glycosaminoglycans and proteoglycans by cyclically stretched valvular cells in 3D culture. Ann Biomed Eng 2008 0.88
25 Mitral valvular interstitial cell responses to substrate stiffness depend on age and anatomic region. Acta Biomater 2010 0.88
26 Failure mechanics of mitral valve chordae tendineae. J Heart Valve Dis 2002 0.87
27 Lysyl hydroxylase 2 induces a collagen cross-link switch in tumor stroma. J Clin Invest 2015 0.86
28 Anisotropic poly(ethylene glycol)/polycaprolactone hydrogel-fiber composites for heart valve tissue engineering. Tissue Eng Part A 2014 0.85
29 Effect of cyclic mechanical strain on glycosaminoglycan and proteoglycan synthesis by heart valve cells. Acta Biomater 2008 0.85
30 Glycosaminoglycan composition of the vocal fold lamina propria in relation to function. Ann Otol Rhinol Laryngol 2008 0.85
31 Emerging trends in heart valve engineering: Part I. Solutions for future. Ann Biomed Eng 2014 0.83
32 Perinatal changes in mitral and aortic valve structure and composition. Pediatr Dev Pathol 2010 0.81
33 Mitral valvular interstitial cells demonstrate regional, adhesional, and synthetic heterogeneity. Cells Tissues Organs 2007 0.80
34 Insight into pathologic abnormalities in congenital semilunar valve disease based on advances in understanding normal valve microstructure and extracellular matrix. Cardiovasc Pathol 2011 0.79
35 Fibronectin-based isolation of valve interstitial cell subpopulations: relevance to valve disease. J Biomed Mater Res A 2010 0.79
36 Differentiating the aging of the mitral valve from human and canine myxomatous degeneration. J Vet Cardiol 2012 0.79
37 Hyaluronan turnover and hypoxic brown adipocytic differentiation are co-localized with ossification in calcified human aortic valves. Pathol Res Pract 2012 0.78
38 Design and validation of a novel splashing bioreactor system for use in mitral valve organ culture. Ann Biomed Eng 2010 0.78
39 Regulation of smooth muscle cell phenotype by glycosaminoglycan identity. Acta Biomater 2010 0.78
40 Extracellular matrix remodeling and cell phenotypic changes in dysplastic and hemodynamically altered semilunar human cardiac valves. Cardiovasc Pathol 2010 0.77
41 Smad2-dependent glycosaminoglycan elongation in aortic valve interstitial cells enhances binding of LDL to proteoglycans. Cardiovasc Pathol 2012 0.77
42 Organ culture as a tool to identify early mechanisms of serotonergic valve disease. J Heart Valve Dis 2010 0.76
43 Age-related structural changes in cardiac valves: implications for tissue-engineered repairs. Am J Geriatr Cardiol 2006 0.76
44 Emerging trends in heart valve engineering: Part II. Novel and standard technologies for aortic valve replacement. Ann Biomed Eng 2014 0.76
45 The role of cell biology and leaflet remodeling in the progression of heart valve disease. Methodist Debakey Cardiovasc J 2010 0.76
46 Emerging trends in heart valve engineering: Part III. Novel technologies for mitral valve repair and replacement. Ann Biomed Eng 2014 0.76
47 Heterogeneity of Mitral Leaflet Matrix Composition and Turnover Correlates with Regional Leaflet Strain. Cardiovasc Eng Technol 2015 0.75
48 Identifying Behavioral Phenotypes and Heterogeneity in Heart Valve Surface Endothelium. Cells Tissues Organs 2016 0.75
49 Functional characterization of fibronectin-separated valve interstitial cell subpopulations in three-dimensional culture. J Heart Valve Dis 2010 0.75
50 The effect of endogenous overexpression of hyaluronan synthases on material, morphological, and biochemical properties of uncrosslinked collagen biomaterials. Biomaterials 2007 0.75